Bertil Lindmark's most recent trade in Galecto Inc was a trade of 115,000 Stock Option (right to buy) done . Disclosure was reported to the exchange on Jan. 4, 2023.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Galecto Inc | Bertil Lindmark | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jan 2023 | 115,000 | 115,000 | - | - | Stock Option (right to buy) | |
| Galecto Inc | Bertil Lindmark | Chief Medical Officer | Purchase of securities on an exchange or from another person at price $ 2.16 per share. | 22 Mar 2022 | 14,604 | 16,604 | - | 2.2 | 31,545 | Common Stock |
| Galecto Inc | Bertil Lindmark | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jan 2022 | 118,750 | 118,750 | - | - | Stock Option (right to buy) | |
| Galecto Inc | Bertil Lindmark | Chief Medical Officer | Purchase of securities on an exchange or from another person at price $ 5.26 per share. | 28 Jun 2021 | 2,000 | 2,000 | - | 5.3 | 10,520 | Common Stock |
| Galecto Inc | Bertil Lindmark | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2021 | 95,000 | 95,000 | - | - | Stock Option (right to buy) |